PGNY
Progyny, Inc.
Data as of 2026-09-05
Company attributes
Price
Interactive 5-year price history chart for PGNY. Latest close $26.61.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency74ExceptionalHealth Care median (n=163) 51
- ValuePrice vs fundamentals69StrongHealth Care median (n=163) 51
- GrowthRevenue & earnings trajectory81ExceptionalHealth Care median (n=163) 50
- MomentumRecent price strength75ExceptionalHealth Care median (n=163) 62
- HealthBalance sheet & solvency76ExceptionalHealth Care median (n=163) 56
- ProfitabilityROE, ROA, ROIC58StrongHealth Care median (n=163) 49
- TechnicalTrend & volatility signals83ExceptionalHealth Care median (n=163) 62
- RiskVolatility & drawdown profile33WeakHealth Care median (n=163) 47
Pillars not shown: Sentiment, ML (Phase 5+).
Fair price check
6 different valuation methods each estimate what PGNY should be worth, then we compare to today's price.
- DCF (2-stage)Fairthinks it's fairly priced — estimates $31.25, about 17% above today
- P/E multiplesFairthinks it's fairly priced — estimates $26.76, about 1% above today
- EV/EBITDAFairthinks it's fairly priced — estimates $25.28, about 5% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $20.35, about 24% below today
- Graham (defensive)Overvaluedthinks it's expensive — estimates $8.77, about 67% below today
- Residual IncomeOvervaluedthinks it's expensive — estimates $5.91, about 78% below today
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $22.82
- Margin of safety(vs fair value)
- -16.6%
- Max (ex-outliers)
- $31.25
- Tangible BVPS
- $5.57
Median of all applicable methods (current price $26.61). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $2.04B |
| Revenue (TTM) | $1.31B |
| Net income (TTM) | $78.63M |
| Operating cash flow (TTM) | $201.25M |
| CapEx (TTM) | $22.86M |
| Free cash flow (TTM)CFO − CapEx | $178.38M |
| Total assets | $715.84M |
| Total liabilities | $262.58M |
| Stockholders' equity | $453.26M |
| Cash & equivalents | $152.63M |
| Shares outstanding | 76.73M |
| EPS (basic) | $1.02 |
| EPS (diluted) | $1.02 |
| P/E ratio (TTM) | 25.96 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-08-07
- Latest period end
- 2026-07-31
- Filing lag
- 29 days
- Missing metrics
- 4(interest_expense, dividends_paid, inventory, long_term_debt)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.